4-Hydroxybenzoic acid (4-HBA) is an aromatic organic acid and a phenolic acid derived from benzoic acid, produced endogenously through the metabolism of tyrosine. Additionally, gut microbial metabolism contributes to its production from dietary sources, making it one of the most abundant phenolic compounds produced by the human gut microbiota.
As a significant breakdown product of dietary tyrosine and a major catechin metabolite after green tea consumption, 4-HBA indicates gut microbiota activity and helps assess intestinal flora balance.
This compound follows different catabolic pathways depending on the organism and environmental conditions.
4-HBA exhibits numerous health benefits including anticancer, neuroprotective and cardioprotective effects. It is also a precursor of coenzyme Q10 (CoQ10).
Sources of 4-HBA include coconut, green tea, olive products, berries, wine, coriander, almonds, and other plants, with production also occurring through bacterial strains in the microbiome.
The compound has notable antioxidant properties, scavenging free radicals to reduce oxidative stress and prevent cellular damage. It also has anti-inflammatory properties and exhibits antimicrobial activity.
Furthermore, 4-HBA's role in modulating gut microbiota composition promotes beneficial microbes while inhibiting harmful bacteria.
Clinically, 4-HBA and related metabolites have demonstrated diagnostic relevance in critically ill patients and those with post-COVID-19 syndrome, serving as potential biomarkers for various disorders and indicating pathological processes through changes in blood concentration.
Accurate and sensitive analytical methods are essential for detecting and quantifying these metabolites.
4-Hydroxybenzoic acid is an aromatic organic acid. It is a phenolic acid derived from benzoic acid, containing a hydroxyl group at the para position of the benzene ring.
4-Hydroxybenzoic acid can be produced endogenously through the metabolism of tyrosine, an aromatic amino acid. [14.]
Additionally, gut microbial metabolism can contribute to the production of 4-hydroxybenzoic acid from dietary sources or other precursors. [9.] 4-hydroxybenzoic acid is one of the most abundant phenolic compounds produced by the human gut microbiota.
For example, it is a major breakdown product of dietary tyrosine as well as being a major catechin metabolite after green tea consumption. It indicates gut microbiota activity and can be used to assess the balance of intestinal flora.
The breakdown of 4-hydroxybenzoic acid can occur through different catabolic pathways, depending on the organism and environmental conditions.
4-HBA has shown anticancer, neuroprotective, and cardioprotective effects. It is also a precursor of coenzyme Q10, which has cardioprotective properties. [6., 8.]
4-hydroxybenzoic acid may also have estrogenic effects. [10.]
The metabolism of 4-hydroxybenzoic acid is closely linked to the degradation pathways of aromatic compounds, particularly those derived from tyrosine and other aromatic amino acids.
Several metabolic pathways have been implicated in the production and breakdown of 4-hydroxybenzoic acid:
4-Hydroxybenzoic acid is an intermediate in the tyrosine degradation pathway, which involves enzymes such as tyrosine aminotransferase and 4-hydroxyphenylpyruvate dioxygenase. [14.]
Certain gut microbes can metabolize dietary compounds or host-derived metabolites, producing 4-hydroxybenzoic acid and other phenolic acids.
These dietary polyphenols, including 4-hydroxybenzoic acid, have significant health benefits mediated through interactions with gut microbiota. They modulate microbial composition, enhance metabolite production, and improve gut barrier function. [15.]
4-Hydroxybenzoic acid is contained in or produced in the degradation of phenolic compounds found in polyphenolic plant compounds including coconut, green tea, olive products, high-anthocyanidin plants like berries, wine, coriander and almonds, as well as in other plant sources by bacteria like Lactobacillus plantarum, Clostridium saccharogumia and Eubacterium ramulus. [7., 9., 11., 14.]
The specific health benefits attributed to microbiota-produced 4-hydroxybenzoic acid include: [15].
Antioxidant Properties:
4-Hydroxybenzoic acid, as a phenolic acid, contributes to the inhibition of oxidative processes by scavenging free radicals, thereby reducing oxidative stress and preventing cellular damage.
Anti-inflammatory Properties:
This compound can reduce inflammation by modulating the production of pro-inflammatory cytokines, thereby helping to alleviate inflammatory conditions, showing some neuroprotective effects. [16.]
Antibacterial Properties:
4-Hydroxybenzoic acid exhibits antimicrobial activity, inhibiting the growth of harmful bacteria and promoting the growth of beneficial bacteria within the gut microbiota.
Gut Microbiota Modulation:
It influences the composition of the gut microbiota, promoting the growth of beneficial microbes like Lactobacillus and Bifidobacterium, and inhibiting harmful bacteria such as Clostridium spp.
Overall, 4-hydroxybenzoic acid is highlighted for its role in enhancing antioxidant defenses, reducing inflammation, exerting antimicrobial effects, and positively modulating gut microbiota to support overall health.
4-Hydroxybenzoic acid can also be formed as a metabolite of certain xenobiotic compounds, such as parabens (used as preservatives), toluene, benzoate and xylene. [2., 7.]
4-hydroxybenzoic acid, along with other metabolites like 4-hydroxyphenyllactic, 4-hydroxyphenylacetic, and phenyllactic acids, has demonstrated diagnostic relevance in critically ill patients and those with post-COVID-19 syndrome.
The aromatic metabolites mentioned, including 4-hydroxybenzoic acid, are potential biomarkers for different disorders, and their concentration changes in blood could indicate pathological processes.
4-hydroxybenzoic acid and other related metabolites are highlighted for their potential utility in diagnosing and predicting outcomes in critically ill patients, emphasizing the importance of accurate and sensitive analytical methods for their detection and quantification.
Organic acids are organic compounds with acidic properties. They include a variety of functional groups like carboxyl, phenol, enol, and thiol, with carboxylic acids having the strongest acidity.
Organic acids are considered weak acids, with those containing phenol, enol, alcohol, or thiol groups being even weaker.
Their structures vary in terms of carbon chain types—aromatic, aliphatic, alicyclic, heterocyclic—saturation, substitutions, and the number of functional groups.
These acids play critical roles in metabolic and catabolic pathways, notably in the tricarboxylic acid cycle inside mitochondria, which is central to energy production in eukaryotes. They are also pivotal in determining the sensory properties of fruits and vegetables.
Organic acid disorders are inherited metabolic conditions that affect the enzymes or transport proteins essential for the breakdown of amino acids, lipids, or carbohydrates. They are marked by the excessive excretion of non-amino organic acids in urine, primarily due to defects in specific enzymes involved in amino acid breakdown that cause buildup of organic acids in tissues.
Conditions can manifest as inborn metabolic disorders of organic acids and amino acids, urea cycle anomalies, and mitochondrial respiratory chain deficiencies.
These disorders are typically passed down through autosomal recessive inheritance. They often present in newborns with symptoms like vomiting and lethargy, progressing to more severe neurological symptoms.
Early diagnosis and intervention are critical and can improve outcomes. Diagnostic methods include urine organic acid analysis via gas chromatography-mass spectrometry (GC/MS).
Current treatments focus on managing symptoms and preventing complications, although definitive therapies are still under research. Treatment focuses may include dietary management, detoxifying harmful metabolites, and in severe cases, organ transplantation.
Continuous monitoring and management are essential for managing symptoms and preventing complications.
Increasingly, research highlights new relationships between the microbiome and human health. Many organisms that comprise the microbiome produce organic acids that can then be tested for additional diagnostic capability.
Certain organic acids in urine like hippuric acid, benzoic acid, and indoleacetic acid are metabolites produced by gut bacteria from the breakdown of amino acids, dietary polyphenols, and other substances.
These acids provide insights into gut health and metabolic functions. For example, elevated levels of certain acids may indicate gut dysbiosis or specific metabolic imbalances, such as phenylketonuria.
Some organic acids known to be produced by the microbiome include:
Benzoic Acid (BA):
Produced from phenylalanine and polyphenol metabolism by intestinal bacteria. High levels in urine can indicate glycine deficiency or liver dysfunction.
Hippuric Acid (HA):
Formed in the liver by conjugation of benzoic acid with glycine. Elevated levels may indicate exposure to environmental toxins like toluene.
Phenylacetic Acid (PAA) and Phenylpropionic Acid (PPA):
These acids result from phenylalanine metabolism by gut bacteria. High urinary levels can suggest dysbiosis or disorders like phenylketonuria. PAA is also associated with depression markers.
4-Hydroxybenzoic Acid (4-HBA) and 4-Hydroxyphenylacetic Acid (4-HPAA):
Derivatives of tyrosine metabolism. 4-HBA is linked to catechin (green tea) metabolism, and 4-HPAA is useful in diagnosing small bowel diseases related to bacterial overgrowth.
3-Hydroxyphenylpropionic Acid (3-HPPA):
A metabolite from dietary polyphenols like proanthocyanidins, indicative of robust bacterial metabolism in the intestines.
3,4-Dihydroxyphenyl Propionic Acid (3,4-DHPPA):
Produced from dietary quinolones by clostridial species, with high levels suggesting an overgrowth.
3-Indoleacetic Acid (IAA): A breakdown product of tryptophan by gut bacteria such as Bifidobacterium and Bacteroides. Elevated levels are seen in conditions like phenylketonuria or dietary changes.
These organic acids are important markers in clinical diagnostics, helping to monitor metabolic disturbances, gut microbiota balance, and exposure to environmental toxins.
Their presence and concentration are influenced by diet, gut microbiota composition, and overall metabolic health, making them valuable indicators in clinical settings for assessing both metabolic and gastrointestinal conditions.
Organic Acid Testing in Functional Medicine
In functional medicine, organic acid testing is utilized to evaluate a patient's metabolic function through a simple urine test. This testing can identify metabolic imbalances that may affect a patient’s mood, energy, and overall health.
Testing provides insights into nutrient deficiencies, dietary habits, toxic exposures, and gut microbiome activity.
The results assist practitioners in customizing treatment plans to address specific metabolic dysfunctions and improve health outcomes.
Additionally, it helps in assessing the impact of microbial metabolism and the efficiency of the Krebs Cycle, aiding in personalized healthcare.
Laboratory testing for organic acids including 4-hydroxybenzoic acid is typically done in urine, although it can also be tested in blood. Testing may be ordered to diagnose an inborn metabolic disorder, or to assess metabolic function and gastrointestinal health in a functional medicine setting.
Urine samples may be collected in a clinical setting; they can also be collected at home. Some labs recommend or require a first morning void sample, to provide a concentrated sample.
Generally, falling within reference ranges for organic acids is recommended, although for many of these organic acids, a level towards the lower end of the reference range is considered optimal.
It is essential to consult with the laboratory company used for their recommended reference range for 4-Hydroxybenzoic Acid.
One company reports the following reference range for 4-hydroxybenzoic acid: <1.43 mcg/mg creatinine [12.]
Elevated levels of 4-hydroxybenzoic acid may signify a plant-based diet high in polyphenols. [8.] Alternatively, it may signify a diet with high levels of food preservatives, as 4-hydroxybenzoic acid or its parent compounds may be used as food preservatives. [1.]
High levels have also been associated with dysbiosis or microbial overgrowth. [8.]
Low levels of 4-hydroxybenzoic acid are not considered clinically relevant.
4-Hydroxybenzoic acid is typically tested along with other organic acids to gain deeper insights into metabolic pathways and physiological processes.
Organic acids that may be tested as part of a panel include:
2-Hydroxybutyric Acid: this acid is a marker for insulin resistance and increased oxidative stress.
2-Hydroxyphenylacetic Acid: derived from phenylalanine metabolism, this acid is used as a biomarker in various metabolic assessments.
3-Hydroxybutyric Acid: a ketone body produced during fat metabolism, indicative of carbohydrate deprivation or ketogenic conditions.
3-Hydroxyisovaleric Acid: an organic acid that accumulates in leucine catabolism disorders, often elevated in maple syrup urine disease.
3-Indoleacetic Acid: a metabolite of tryptophan, it is significant in the study of serotonin pathways and plant growth regulation.
4-Hydroxyphenylacetic Acid: a breakdown product of tyrosine, used in diagnosing disorders involving the degradation of aromatic amino acids.
5-Hydroxyindoleacetic Acid: the main metabolite of serotonin, used as a marker in the diagnosis of carcinoid syndrome.
Adipic Acid: a dicarboxylic acid that can also be formed metabolically in humans through the oxidation of certain fatty acids.
a-Keto-b-Methylvaleric Acid: an intermediate in isoleucine metabolism, which can accumulate in certain metabolic disorders.
a-Ketoisocaproic Acid: an intermediate in the metabolism of leucine, elevated in maple syrup urine disease.
a-Ketoisovaleric Acid: a breakdown product of valine metabolism, also linked to maple syrup urine disease.
a-Ketoglutaric Acid: a key intermediate in the citric acid cycle, essential for energy production and nitrogen transport.
Benzoic Acid: produced from phenylalanine and polyphenol metabolism by intestinal bacteria. High levels in urine can indicate glycine deficiency or liver dysfunction.
Cis-Aconitic Acid: an intermediate in the tricarboxylic acid cycle, formed by the dehydration of citric acid.
Citric Acid: a central compound in the citric acid cycle, crucial for energy production in cells.
Ethylmalonic Acid: this acid accumulates in ethylmalonic encephalopathy and is involved in fatty acid metabolism.
Fumaric Acid: an intermediate in the tricarboxylic acid (TCA) cycle, participating in energy production through its conversion to malate and subsequent participation in the generation of ATP.
Homovanillic Acid: a major metabolite of dopamine, used as a marker to monitor dopamine levels.
Hippuric Acid: formed from the conjugation of benzoic acid and glycine; elevated levels can indicate exposure to certain environmental toxins.
Hydroxymethylglutarate: an intermediate in leucine metabolism, also associated with disorders of ketogenesis and ketolysis.
Isocitric Acid: an isomer of citric acid and an important part of the citric acid cycle, pivotal in cellular energy production.
Kynurenic Acid: a product of tryptophan metabolism, known for its role as a neuroprotective agent.
Lactic Acid: produced from pyruvate via anaerobic metabolism, an indicator of hypoxia and strenuous exercise.
Malic Acid: a dicarboxylic acid found in fruits, and involved in the citric acid cycle.
Methylmalonic Acid: an indicator of Vitamin B12 deficiency, it accumulates when the vitamin is deficient.
Methylsuccinic Acid: a dicarboxylic acid often involved in alternative pathways of fatty acid metabolism.
Orotic Acid: involved in the metabolism of pyrimidines, abnormalities in its levels can indicate metabolic disorders.
Pyroglutamic Acid: an uncommon amino acid derivative that can accumulate in glutathione synthesis disorders.
Pyruvic Acid: a key intersection in several metabolic pathways; its levels are crucial for assessing cellular respiration and metabolic function.
Quinolinic Acid: a neuroactive metabolite of the kynurenine pathway, elevated levels are associated with neurodegenerative diseases.
Suberic Acid: a dicarboxylic acid that is a biomarker in adipic aciduria, often studied in relation to fatty acid oxidation disorders.
Succinic Acid: a four-carbon dicarboxylic acid that plays a central role in the Krebs cycle, crucial for energy production.
Tricarballylic Acid: an organic acid that can inhibit aconitase in the citric acid cycle and is sometimes associated with glyphosate exposure.
Vanillylmandelic Acid: a metabolite of epinephrine and norepinephrine, used as a marker for neuroblastoma and other catecholamine-secreting tumors.
Click here to compare testing options and order organic acid testing.
[1.] 4-Hydroxybenzoic Acid WORKPLACE ENVIRONMENTAL EXPOSURE LEVEL .; 2016. Accessed May 24, 2024. https://www.tera.org/OARS/Hydroxybenzoic%20Acid%20%2899-96-7%29%20WEEL%202016%20public%20comment.pdf
[2.] Ball AL, Solan ME, Franco ME, Lavado R. Comparative cytotoxicity induced by parabens and their halogenated byproducts in human and fish cell lines. Drug Chem Toxicol. 2023 Nov;46(4):786-794. doi: 10.1080/01480545.2022.2100900. Epub 2022 Jul 19. PMID: 35854652.
[3.] Beley GJ, Anne M, Dadia DM. Nutrigenomics in the management and prevention of metabolic disorders. Elsevier eBooks. Published online January 1, 2023:209-274. doi:https://doi.org/10.1016/b978-0-12-824412-8.00006-0
[4.] Chahardoli A, Jalilian F, Memariani Z, Farzaei MH, Shokoohinia Y. Analysis of organic acids. Recent Advances in Natural Products Analysis. Published online 2020:767-823. doi:https://doi.org/10.1016/b978-0-12-816455-6.00026-3
[5.] French D. Advances in Clinical Mass Spectrometry. Advances in Clinical Chemistry. 2017;79:153-198. doi:https://doi.org/10.1016/bs.acc.2016.09.003
[6.] Herebian D, Seibt A, Smits SHJ, Rodenburg RJ, Mayatepek E, Distelmaier F. 4-Hydroxybenzoic acid restores CoQ10 biosynthesis in human COQ2 deficiency. Ann Clin Transl Neurol. 2017 Oct 17;4(12):902-908. doi: 10.1002/acn3.486. PMID: 29296619; PMCID: PMC5740244.
[7.] Human Metabolome Database: Showing metabocard for 4-Hydroxybenzoic acid (HMDB0000500). hmdb.ca. https://hmdb.ca/metabolites/HMDB0000500
[8.] Hurtado-Barroso S, Quifer-Rada P, Marhuenda-Muñoz M, Rinaldi de Alvarenga JF, Tresserra-Rimbau A, Lamuela-Raventós RM. Increase of 4-Hydroxybenzoic, a Bioactive Phenolic Compound, after an Organic Intervention Diet. Antioxidants (Basel). 2019 Aug 24;8(9):340. doi: 10.3390/antiox8090340. PMID: 31450569; PMCID: PMC6769758.
[9.] Lee YT, Huang SQ, Lin CH, Pao LH, Chiu CH. Quantification of Gut Microbiota Dysbiosis-Related Organic Acids in Human Urine Using LC-MS/MS. Molecules. 2022 Aug 23;27(17):5363. doi: 10.3390/molecules27175363. PMID: 36080134; PMCID: PMC9457824.
[10.] Lemini C, Silva G, Timossi C, Luque D, Valverde A, González-Martínez M, Hernández A, Rubio-Póo C, Chávez Lara B, Valenzuela F. Estrogenic effects of p-hydroxybenzoic acid in CD1 mice. Environ Res. 1997 Nov;75(2):130-4. doi: 10.1006/enrs.1997.3782. PMID: 9417843.
[11.] Rowland I, Gibson G, Heinken A, Scott K, Swann J, Thiele I, Tuohy K. Gut microbiota functions: metabolism of nutrients and other food components. Eur J Nutr. 2018 Feb;57(1):1-24. doi: 10.1007/s00394-017-1445-8. Epub 2017 Apr 9. PMID: 28393285; PMCID: PMC5847071.
[12.] Rupa Health. Organic Acids Sample Report.pdf. Google Docs. Accessed May 2, 2024. https://drive.google.com/file/d/1UJk_PcOslDhV5WjuyYqGQ1CwHLU43skK/view
[13.] Seashore M. The Organic Acidemias: An Overview.; 2001. Accessed May 2, 2024. https://corpora.tika.apache.org/base/docs/govdocs1/141/141031.pdf
[14.] Sobolev PD, Burnakova NA, Beloborodova NV, Revelsky AI, Pautova AK. Analysis of 4-Hydroxyphenyllactic Acid and Other Diagnostically Important Metabolites of α-Amino Acids in Human Blood Serum Using a Validated and Sensitive Ultra-High-Pressure Liquid Chromatography-Tandem Mass Spectrometry Method. Metabolites. 2023 Nov 3;13(11):1128. doi: 10.3390/metabo13111128. PMID: 37999224; PMCID: PMC10673366.
[15.] Wang X, Qi Y, Zheng H. Dietary Polyphenol, Gut Microbiota, and Health Benefits. Antioxidants (Basel). 2022 Jun 20;11(6):1212. doi: 10.3390/antiox11061212. PMID: 35740109; PMCID: PMC9220293.
[16.] Winter AN, Brenner MC, Punessen N, Snodgrass M, Byars C, Arora Y, Linseman DA. Comparison of the Neuroprotective and Anti-Inflammatory Effects of the Anthocyanin Metabolites, Protocatechuic Acid and 4-Hydroxybenzoic Acid. Oxid Med Cell Longev. 2017;2017:6297080. doi: 10.1155/2017/6297080. Epub 2017 Jun 27. PMID: 28740571; PMCID: PMC5504963.